Manoush MasarratChief Executive Officer
Manoush Masarrat has extensive Executive and Management experience in the Medical Technology industry and until recently was CEO of ExScale BioSpecimen Solutions AB. His career has included several strategic C-suite roles in Sales and Marketing, his area of outstanding expertise. Mr Masarrat has a BSc. in Industrial Economics from Gävle University (Sweden) and MSc. Courses in International Business Management from Macquarie University in Sydney, Australia.
Lena HefflerDirector of Business Development
A trained clinical immunologist with a research-based M.Sc. from Karolinska Institutet and a M.Sc. in biochemistry from Uppsala University, Lena Heffler has held executive and strategic roles at Aerocrine, Philips and Agilent Technologies amongst others. Results and solutions oriented, Lena has exceptional strategic insight and experience in both labtech and medtech development and sales.
Per GerdeChief Scientific Officer
Associate Professor of Inhalation Toxicology. Scientist at the Division of Physiology, Institute of Environmental Medicine at the Karolinska Institutet. Previous appointments include scientist at the Lovelace Respiratory Research Institute (1993– 1998), scientist at the Swedish National Institute of Occupational Health (1991–1996), and postdoctoral fellow at the Lovelace Respiratory Research Institute (1989–1991). Dr. Gerde has published approx. 30 peer reviewed scientific papers. He is also the main inventor of six patent families with related patent applications.
Michael OwensChief Financial Officer
With a BSBA (Bachelor Business Administration in accounting and auditing Michael Owens has held executive finance positions in both the US and Sweden. From 2007 – 2012 he was Group Controller of Karolinska Development, playing a key role in successfully taking the company public in 2011. He has extensive executive experience in the medtech research field, guiding companies surely through a complex legislative and fiscal landscape.
Maria MalmlöfDirector of Projects
With a M.Sc. in Biotechnology from Sweden’s KTH Royal Institute of Technology and PhD research ongoing, Maria Malmlöf has co-authored a list of publications in inhalation R&D, specializing in in vitro dissolution. Maria has played a key role in the evolution of ISAB’s in vitro dissolution system DissolvIt and its 3D cell culturing technology XposeALI. As ISAB’s Director of Projects her expertise and experience guides all ongoing customer and contract research and development projects.